Prostaglandin E2 protects intestinal tumors from nonsteroidal anti-inflammatory drug-induced regression in Apcmin/+ mice

Cancer Research

Volumn 62, Issue 2, 2002, Pages 403-408

  Hansen Petrik, Melissa B ^a   McEntee, Michael F ^a   Jull, Brian ^a   Shi, Hang ^a   Zemel, Michael B ^a   Whelan, Jay ^a  

^a UNIVERSITY OF TENNESSEE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NONSTEROID ANTIINFLAMMATORY AGENT; PIROXICAM; PROSTAGLANDIN E RECEPTOR; PROSTAGLANDIN E2; PROSTAGLANDIN E2 DERIVATIVE; PROSTAGLANDIN SYNTHASE; RECEPTOR SUBTYPE; SULINDAC;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CALCIUM CELL LEVEL; CALCIUM MOBILIZATION; CALCIUM SIGNALING; COLON POLYPOSIS; CONTROLLED STUDY; ENZYME INHIBITION; INTESTINE TUMOR; MALE; MITOSIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS; TUMOR GROWTH;

16,16-DIMETHYLPROSTAGLANDIN E2; ADENOMATOUS POLYPOSIS COLI; ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTIBODIES, MONOCLONAL; APOPTOSIS; CALCIUM; CYCLOOXYGENASE INHIBITORS; DINOPROSTONE; DISEASE MODELS, ANIMAL; DRUG INTERACTIONS; INTESTINE, SMALL; MALE; MICE; MICE, INBRED C57BL; MITOSIS; PIROXICAM; RECEPTORS, PROSTAGLANDIN E; SULINDAC;

EID: 0037081178     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (73)

1. Deaths. Final data for 1998
2. Studying cancer in the mouse
3. Lessons from hereditary colorectal cancer
4. Inactivation of both APC alleles in human and mouse tumors
5. Somatic mutations of the APC gene in colorectal tumors: Mutation cluster region in the APC gene
6. APC mutations occur early during colorectal tumorigenesis
7. Molecular determinants of dysplasia in colorectal lesions
8. The APC gene product in normal and tumor cells
9. Cyclooxygenase 2 is up-regulated and localized to macrophages in the intestine of Min mice
10. Elevated cyclooxygenase-2 levels in Min mouse adenomas
11. Expression of prostaglandin G/H synthase-1 and -2 protein in human colon cancer
12. Altered eicosanoid levels in human colon cancer
13. 2
14. Sulindac, causes rapid regression of preexisting tumors in Min/+ mice independent of prostaglandin biosynthesis
15. Chemoprevention of spontaneous intestinal adenomas in the adenomatous polyposis coli Min mouse model with aspirin
16. Cyclooxygenase-2 overexpression and tumor formation are blocked by sulindac in a murine model of familial adenomatous polyposis
17. Min/+ mice
18. Min/+ mice
19. Min/+ mice
20. Aspirin prevents tumors in a murine model of familial adenomatous polyposis
21. Min mouse by piroxicam: Kinetics, strain effects and resistance to chemosuppression
22. The cyclooxygenase-2 inhibitor celecoxib is a potent preventive and therapeutic agent in the Min mouse model of adenomatous polyposis
23. Suppression of intestinal polyp development by nimesulide, a selective cyclooxygenase-2 inhibitor, in Min mice
24. Genetic disruption of Ptgs-1, as well as Ptgs-2, reduces intestinal tumorigenesis in Min mice
25. Δ71σ knockout mice by inhibition of cyclooxygenase 2 (COX-2)
26. Inhibition of NF-κB and AP-1 activation by R- and S-flurbiprofen
27. Min/+ (MIN) mouse with R-flurbiprofen
28. Induction of apoptotic cell death in human colorectal carcinoma cell lines by a cyclooxygenase-2 (COX-2)selective non-steroidal anti-inflammatory drug: Independence from COX-2 protein expression
29. The effect of non-steroidal antiinflammatory drugs on human colorectal cancer cells: Evidence of different mechanisms of action
30. Malignant transformation and antineoplastic actions of nonsteroidal antiinflammatory drugs (NSAIDs) on cyclooxygenase-null embryo fibroblasts
31. 15-Lipoxygenase-1 mediates nonsteroidal anti-inflammatory drug-nduced apoptosis independently of cyclooxygenase-2 in colon cancer cells
32. Mechanisms underlying nonsteroidal antiinflammatory drug-mediated apoptosis
33. Ceramide-β-D-glucuronide. Synthesis, digestion, and suppression of early markers of colon carcinogenesis
34. Cyclooxygenase-independent induction of p21 WAF-1/C1P-1, apoptosis and differentiation by L-745,337 and salicytate in HT-29 colon cancer cells
35. Relationship of β-catenin and Bcl-2 expression to sulindac-induced regression of intestinal tumors in Min mice
36. Apc gene mutation is associated with a dominant-negative effect upon intestinal cell migration
37. Peroxisome proliferator-activated receptors α and γ are activated by indomethacin and other non-steroidal anti-inflammatory drugs
38. Sulindac inhibits activation of the NF-κB pathway
39. Exisulind induction of apoptosis involves guanosine 3′,5′-cyclic monophosphate phosphodiesterase inhibition, protein kinase G activation, and attenuated β-catenin
40. Crypt stem cell survival in the mouse intestinal epithelium is regulated by prostaglandins synthesized through cyclooxygenase-1
41. 2
42. Role of intracellular calcium in human adipocyte differentiation
43. The development of a method for the preparation of rat intestinal epithelial cell primary cultures
44. 2+ indicators with greatly improved fluorescent properties
45. Sulindac inhibits colorectal tumor growth, but not prostaglandin synthesis in the rat
46. Prostaglandin levels in human colorectal mucosa: Effects of sulindac in patients with familial adenomatous polyposis
47. Tissue prostaglandin levels in familial adenomatous polyposis patients treated with sulindac
48. Tissue prostanoids as biomarkers for chemoprevention of colorectal neoplasia: Correlation between prostanoid synthesis and clinical response in familial adenomatous polyposis
49. Differential expression of matrilysin and cyclooxygenase-2 in intestinal and colorectal neoplasms
50. Localization of cyclooxygenase-2 in human sporadic colorectal adenomas
51. Specific inhibition of cyclooxygenase 2 restores antitumor reactivity by altering the balance of IL-10 and IL- 12 synthesis
52. t in colon carcinogenesis
53. Cellular localization of mRNAs for prostaglandin E receptor subtypes in mouse gastrointestinal tract
54. Ligand binding specificities of the eight types and subtypes of the mouse prostanoid receptors expressed in Chinese hamster ovary cells
55. Characterization of the signal transduction of prostaglandin E receptor EPI subtype in cDNA-transfected Chinese hamster ovary cells
56. Prostaglandin E receptors in myometrial cells
57. 2: Cross-talk regulation by protein kinase C
58. n-3 PUFA dietary supplementation inhibits proliferation and store-operated calcium influx in thymoma cells growing in Balb/c mice
59. 2+ mobilization
60. Nonsteroidal anti-inflammatory drugs attenuate epidermal growth factor-induced proliferation independent of prostaglandin synthesis inhibition
61. Store-operated calcium influx in human gastric cells: Role of endogenous prostaglandins
62. The mRNA of L-type calcium channel elevated in colon cancer: Protein distribution in normal and cancerous colon
63. Calcium/calmodulin-dependent protein kinase type IV (CaMKIV) inhibits apoptosis induced by potassium deprivation in cerebellar granule neurons
64. Epidermal growth factor-induced cytoprotection in human intestinal cells involves intracellular calcium signaling
65. Combinatorial chemoprevention of intestinal neoplasia
66. Prostaglandin E receptors
67. The effect of exogenous prostaglandin administration on tumor size and yield in Min/+ mice
68. 2 on gastrointestinal tumorigenesis induced by N-methyl-N′-nitrosoguanidine in rats: Glandular epithelium of stomach and duodenum
69. Growth inhibition by 8-chloro cyclic AMP of human HT29 colorectal and ZR-75-1 breast carcinoma xenografts is associated with selective modulation of protein kinase A isoenzymes
70. Experimental gene therapy of human colon cancer
71. 4
72. Positive and negative regulation of cell proliferation through prostaglandin receptors in NIH-3T3 cells
73. Roles of prostaglandin E receptors in mesangial cells under high-glucose conditions